Criteria for discontinuation of vaccination programmes using bacille calmette-guerin (BCG) in countries with a low prevalence of tuberculosis. A statement of the International Union Against Tuberculosis and Lung Disease

Tubercle and Lung Disease

Volumn 75, Issue 3, 1994, Pages 179-180

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

BCG VACCINATION; HUMAN; PREVALENCE; SHORT SURVEY; TUBERCULOSIS;

BCG VACCINE; CHILD, PRESCHOOL; HUMAN; IMMUNIZATION PROGRAMS; INFANT; INFANT, NEWBORN; PREVALENCE; TUBERCULOSIS; TUBERCULOSIS, MENINGEAL; TUBERCULOSIS, PULMONARY;

EID: 0028338735     PISSN: 09628479     EISSN: None     Source Type: Journal    
DOI: 10.1016/0962-8479(94)90003-5     Document Type: Article

References (9)

1. The effects of the scheme for BCG vaccination of schoolchildren in England and Wales and the consequences of discontinuing the scheme at various dates
2. BCG vaccination and epidemiological situation: a decision making approach to the use of BCG
3. Impact of BCG vaccination programmes in children and young adults on the tuberculosis problem
4. Practical consequences of estimating the risk of infection on the policy making in Sweden
5. Childhood tuberculosis in Sweden. An epidemiological study made six years after the cessation of general BCG vaccination in the newborn
6. Experience in Sweden 15 years after stopping general BCG vaccination at birth
7. BCG complications
8. Second IUATLD study on complications induced by intradermal BCG-vaccination
9. The impact of changing BCG coverage on tuberculosis incidence in Swedish-born children between 1969 and 1989